# Survival Outcomes of Residual Disease in Triple-Negative Breast Cancer

> clinical trial · VERIFIED · 2026-07-20

Status: COMPLETED · Sponsor: Sohag University · Condition: Triple-Negative Breast Cancer (TNBC)

- Company: Sohag University
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT07714382

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.